Octapharma Accepting Applications for Research Grants on Immunotherapy, Coagulation Disorders, and Critical Care
Octapharma Accepting Applications for Research Grants on Immunotherapy, Coagulation Disorders, and Critical Care
Octapharma, a plasma products manufacturer, is accepting applications for the Octapharma 25th Anniversary Grants Program. The program supports research that helps promote excellence in patient care and provides valuable information to the medical and patient community that may translate to better management of disease and improvement in patient safety and population health.
The grant program will support selected clinical and pre-clinical research projects focusing on human protein therapies in one or more of the following therapeutics areas: immunotherapy, coagulation disorders, and intensive care and emergency medicine.
The program is only open to researchers based in the United States and is administered by Octapharma USA, the Swiss company's U.S. subsidiary.
Grant applications will be accepted online at the grants program Web site. The Octapharma Grants Committee will meet every six months, in October and April, to review all applications received.
Visit the grants program Web site for complete program guidelines.
Contact:
Link to Complete RFP
Primary Subject: Medical Research
Geographic Funding Area: National
Looking for additional funders in the field of Medical Research?
The Foundation Directory Online allows you to search the universe of grantmakers using 12 different search fields, including fields of interest, types of support, and geographic focus. Take a guided tour today!
| 
print
e-mail
